Navigation Links
Aethlon Medical Clarifies News Report
Date:4/20/2011

elopment of exosome-targeted products and services that improve cancer diagnosis, provide post-treatment cancer surveillance, and aid in the discovery of biomarkers that allow doctors to optimize patient therapy.  Additional information regarding Aethlon Medical and Exosome Sciences can be accessed online at www.aethlonmedical.com.

Certain of the statements herein may be forward-looking and involve risks and uncertainties.  Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements.  Such potential risks and uncertainties include, without limitation, the capability of the Hemopurifier® to reduce viral loads and other disease conditions or to identify or treat disease conditions such as cancer, including the ability to capture exosomes and the impact that potential ability may have on disease conditions, the Company's ability to raise capital when needed, including obtaining government grants, the Company's ability to complete the development of its planned products, the ability of the Company to obtain FDA and other regulatory approvals permitting the sale of its products, the ability to achieve commercialization in India as a result of the proposed treatment program at Medanta, The Medicity Institute, whether successful or not, the ability of the Hemopurifier® to improve the efficacy of SOC therapy against HCV, the Company's ability to manufacture its products either internally or through outside companies and to create future generations of the Hemopurifier®, the
'/>"/>

SOURCE Aethlon Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Aethlon Medical to Present at the 2009 RedChip Small-Cap Investor Conference on June 16, 2009
2. Aethlon Medical Announces Presentation of Hepatitis-C (HCV) Clinical Data at 42nd Annual American Society of Nephrology (ASN) Conference
3. Aethlon Medical Releases Medical Device Data Against the H1N1 Swine Flu Virus
4. Aethlon Medical Discloses Live Webcast of Todays BIOCOM Presentation
5. Aethlon Medical Announces Expansion of Hepatitis C Virus (HCV) Treatment Programs
6. Aethlon Medical Announces Approval of Hepatitis C Virus (HCV) Treatment Program
7. Aethlon Medical to Present at Rodman & Renshaw Annual Global Investment Conference
8. Aethlon Medical Reestablishes Biodefense Programs
9. Aethlon Medical Engages Fabiani & Company to Advance U.S. Government Partnerships
10. Aethlon Medical Announces Appointment of Rod Kenley to Its Board of Directors
11. Aethlon Medical Names Rod Kenley President
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... WASHINGTON , Jan. 23, 2015  A new analysis ... Part D 2015 enrollment data shows that 81 percent ... convenient access and extra discounts at certain pharmacies. The ... "Preferred pharmacy plans are now the foundation of ...
(Date:1/23/2015)... 2015 /PRNewswire/-- Harwood Feffer LLP ( www.hfesq.com ) is investigating ... Inc. ("Advaxis" or the "Company") (NASDAQ: ADXS ... duties to shareholders. On January 21, 2015, ... that Advaxis had misrepresented the clinical data for its ...
(Date:1/23/2015)... N.Y. , Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. ... its Phase I trial of Lixte,s lead compound, LB‑100, is ... John S. Kovach , M.D., the founder ... planned to be completed at a single site. Accrual of ...
Breaking Medicine Technology:New Analysis: 81 Percent of Medicare Part D Seniors Choose "Preferred Pharmacy" Plans in 2015 2Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3
... 2011 Archimedes Pharma Ltd., and its subsidiary, Archimedes ... spray is now available by prescription in U.S. pharmacies. ... in cancer patients 18 years of age and older ... opioid therapy for their underlying persistent cancer pain. The ...
... Reportlinker.com announces that a new ... its catalogue: Bare ... Analysis, Competitive Landscape and Market Forecasts ... http://www.reportlinker.com/p0656885/Bare-Metal-Stents-BMS---Global-Pipeline-Analysis-Competitive-Landscape-and-Market-Forecasts-to-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Cardiovascular_Devices Bare Metal ...
Cached Medicine Technology:Archimedes Pharma Launches Lazanda® - the Only Fentanyl Nasal Spray for the Management of Breakthrough Pain in Cancer in the U.S. 2Archimedes Pharma Launches Lazanda® - the Only Fentanyl Nasal Spray for the Management of Breakthrough Pain in Cancer in the U.S. 3Archimedes Pharma Launches Lazanda® - the Only Fentanyl Nasal Spray for the Management of Breakthrough Pain in Cancer in the U.S. 4Archimedes Pharma Launches Lazanda® - the Only Fentanyl Nasal Spray for the Management of Breakthrough Pain in Cancer in the U.S. 5Archimedes Pharma Launches Lazanda® - the Only Fentanyl Nasal Spray for the Management of Breakthrough Pain in Cancer in the U.S. 6Archimedes Pharma Launches Lazanda® - the Only Fentanyl Nasal Spray for the Management of Breakthrough Pain in Cancer in the U.S. 7Bare Metal Stents (BMS) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 2Bare Metal Stents (BMS) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 3Bare Metal Stents (BMS) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 4Bare Metal Stents (BMS) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 5Bare Metal Stents (BMS) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 6Bare Metal Stents (BMS) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 7Bare Metal Stents (BMS) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 8Bare Metal Stents (BMS) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 9Bare Metal Stents (BMS) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 10Bare Metal Stents (BMS) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 11Bare Metal Stents (BMS) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 12Bare Metal Stents (BMS) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 13
(Date:1/22/2015)... New York (PRWEB) January 22, 2015 The ... ) in the U.S. District Court, Southern District of West ... Bard, Inc. in that proceeding’s first bellwether trial. In an ... for a new trial after finding that C.R. Bard had ...
(Date:1/22/2015)... 22, 2015 Thousand of GranuFlo lawsuits ... recalled its GranuFlo and NaturaLyte dialysis concentrates continue to ... U.S. District Court, District of Massachusetts, Bernstein Liebhard LLP ... Court has remanded a case filed by the state ...
(Date:1/22/2015)... Carinsurancesavings.biz has released a new blog post ... insurance . , Purchasing an accidental death and dismemberment ... This type of rider provides benefits if the insured dies ... a lesser form of life insurance. , AD&D is ...
(Date:1/22/2015)... 2015 Yesterday, Senator Holly Mitchell ... Kristin Olsen (R-Modesto) were honored by the California ... biotechnology, biomedical science, medical device and pharmaceutical innovation ... the “2014 Life Sciences Champion” award from CHI ...
(Date:1/22/2015)... Colorado (PRWEB) January 22, 2015 Four years since ... Queen – which coincided with the marriage of Avasa & Matthew ... THE ROAD, which is scheduled for release through White Swan Records ... message that there is a sacred path available to all of ...
Breaking Medicine News(10 mins):Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4
... the October 15 issue of the Journal of Clinical ... (CASQ), a new self-completed instrument to measure excessive daytime ... C. Spilsbury, PhD, of the Division of Clinical Epidemiology ... of 411 adolescents between 11-17 years of age, who ...
... Oct. 15 With school schedules now routine and,the ... "not again",sighs. This might be a good time to ... (Photo: http://www.newscom.com/cgi-bin/prnh/20071015/NYFNSL01 ) The following are ... lunch and snacks for greater nutritional impact. Add a,handful ...
... Gewurzmuller,s 2006 Sales Totalled US$ 65 M (About Euro 46 M),Frutarom Establishes its ... ... Field Frutarom Continues to Implement ... TASE: FRUT, OTC: FRUTF.PK) ("Frutarom") announced today,that it has signed an agreement to ...
... ,Real Women, Real Pain, Campaign Highlights the Suffering Caused ... the World Today, the International Association for the ... Against Pain in Women to draw attention to,the significant ... for more,effective care. Lack of awareness of pain issues ...
... Shows Nearly 1 in 3 Believe Nothing Can Be ... Crime as Greatest Risk to Well-Being, CHICAGO, Oct. ... can be done to prevent accidental injuries, posing a ... in the,United States, according to a national survey of ...
... study by Rhode Island Hospital and Brown University researchers reported ... not receive the initial psychiatric clearance for the surgery. The ... to clear candidates for surgery, and the largest to determine ... the reasons for exclusion. It was published in the October ...
Cached Medicine News:Health News:New tool to assess excessive daytime sleepiness in adolescents published in JCSM 2Health News:Fresh, Tasty - Healthy - Lunch and Snack Ideas 2Health News:Frutarom Acquires Gewurzmuller, a Company Specializing in Unique Savory Flavors 2Health News:Frutarom Acquires Gewurzmuller, a Company Specializing in Unique Savory Flavors 3Health News:Frutarom Acquires Gewurzmuller, a Company Specializing in Unique Savory Flavors 4Health News:Frutarom Acquires Gewurzmuller, a Company Specializing in Unique Savory Flavors 5Health News:International Association for the Study of Pain (IASP) Declares the Global Year Against Pain in Women 2Health News:International Association for the Study of Pain (IASP) Declares the Global Year Against Pain in Women 3Health News:Americans' Pessimistic View of Accident Prevention Poses Hurdle to Reducing Injuries, Survey Says 2Health News:Americans' Pessimistic View of Accident Prevention Poses Hurdle to Reducing Injuries, Survey Says 3Health News:1 in 5 bariatric surgery candidates not psychologically cleared for surgery 2
... IMMAGE Immunochemistry System gives you ... to perform accurate testing for ... It also delivers a wealth ... your laboratory to streamline its ...
... Array systems are fully automated ... fast turnaround of highly accurate ... drug monitoring (TDM) results. Using ... the easy-to-use Array® 360 performs ...
Inquire...
ELISA kit for detection of Rheumatoid Factor....
Medicine Products: